Niagen Bioscience, Inc. (NAGE)
4.89
+0.16
(+3.38%)
USD |
NASDAQ |
Apr 24, 11:43
Niagen Bioscience Market Cap : 391.59M for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SIGA Technologies, Inc. | 331.71M |
| Nephros, Inc. | 30.23M |
| Clover Health Investments Corp. | 1.270B |
| Corcept Therapeutics, Inc. | 4.820B |
| Protalix Biotherapeutics, Inc. | 174.44M |
Market Cap Related Metrics
| PE Ratio | 23.94 |
| PS Ratio | 3.217 |
| PEG Ratio | 0.2550 |
| Price to Book Value | 5.117 |
| Price to Free Cash Flow | 31.67 |
| Price | 4.89 |
| Earnings Yield | 4.18% |
| PEGY Ratio | 0.2550 |
| Operating PE Ratio | 29.12 |
| Normalized PE Ratio | 23.91 |